An IPO for Those Who Think Love and Money Is a Match
The Match Group, home of the hugely popular dating apps and sites Tinder, Match, Chemistry, OurTime, and OkCupid, will issue an IPO in the fourth quarter. Mashable is calling it “the world’s flirtiest IPO.” Barry Diller’s InterActive Corp. (IAC), which owns the Match Group and a slew of other Internet brands, also appointed Joey Levin, formerly the CEO of IAC’s Search & Applications, CEO of IAC.
Back in 1995 when Match.com first debuted, people were skeptical of online dating, but today, dating apps and sites are big business. According to IBISWorld, dating sites are expected to bring in $1.17 billion in revenue this year, with apps totaling another $628.8 million. Online dating accounts for 48.7 percent of the revenue from U.S. dating services, but mobile dating apps such as Tinder are on the rise with 26.2 percent of the market.
The largest dating service companies are the Match Group, eHarmony, Zoosk, Plenty of Fish, and Spark Networks. The Match Group leads the category, with nearly 22 percent share of the market. The Wall Street Journal reported the Match Group accounted for nearly one-third, or 29 percent, of IAC’s overall revenue in 2014. In the most recent quarter, the Match Group’s revenue was $239.2 million, or 30 percent of IAC’s revenue of $772.5 million.
With their portfolio of dating sites in more than 200 countries the Match Group is well positioned to market to the large generation of millennials worldwide. More than 7 million people sign up for their products every month.
As for what the Match Group’s ticker symbol might be on the stock exchange, the company’s lips are sealed. Many of the good ones are already taken. LOV belongs to rival Spark Networks, owner of JDate.com, ChristianMingle.com, and BlackSingles.com. DATE is the ticker symbol for Jiayuan, China’s largest dating site. LUV is taken by Southwest Airlines. Arrythmia Research Technology has HRT.
Apparently KISS is still available—if the Match Group gets lucky.
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.